Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03345810
Title Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AIO-Studien-gGmbH
Indications

lung non-small cell carcinoma

Therapies

Gemcitabine + Vinorelbine

Carboplatin + Nab-paclitaxel

Carboplatin + Durvalumab + Nab-paclitaxel

Durvalumab + Gemcitabine + Vinorelbine

Age Groups: senior
Covered Countries DEU

Additional content available in CKB BOOST